These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4270973)

  • 1. Protective effect of phenobarbitone against fulvine-induced hepatic damage and hypertensive pulmonary vascular disease in the rat.
    Khaliq SU
    Cardiovasc Res; 1973 Sep; 7(5):655-63. PubMed ID: 4270973
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulvine and the pulmonary circulation.
    Kay JM; Heath D; Smith P; Bras G; Summerell J
    Thorax; 1971 May; 26(3):249-61. PubMed ID: 4253539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive pulmonary vascular disease produced in rats by administration of the pyrrolizidine alkaloid fulvine.
    Kay JM; Heath D; Smith P; Bras G; Summerell J
    J Pathol; 1971 Feb; 103(2):P3. PubMed ID: 5567927
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of phenobarbitone, cinnarizine, and zoxazolamine on the development of right ventricular hypertrophy and hypertensive pulmonary vascular disease in rats treated with monocrotaline.
    Kay JM; Smith P; Heath D; Will JA
    Cardiovasc Res; 1976 Mar; 10(2):200-5. PubMed ID: 132989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats.
    Hislop A; Reid L
    Br J Exp Pathol; 1974 Apr; 55(2):153-63. PubMed ID: 4835803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on development of cor pulmonale in nonhuman primates following pyrrolizidine alkaloid intoxication.
    Allen JR; Chesney CF
    Exp Mol Pathol; 1972 Oct; 17(2):220-32. PubMed ID: 4627457
    [No Abstract]   [Full Text] [Related]  

  • 7. LESIONS IN THE LUNGS AND LIVERS OF RATS POISONED WITH THE PYRROLIZIDINE ALKALOID FULVINE AND ITS N-OXIDE.
    BARNES JM; MAGEE PN; SCHOENTAL R
    J Pathol Bacteriol; 1964 Oct; 88():521-31. PubMed ID: 14226424
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in pulmonary structure and function induced by monocrotaline intoxication.
    Ghodsi F; Will JA
    Am J Physiol; 1981 Feb; 240(2):H149-55. PubMed ID: 6451183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
    Nakashima M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced lung disease.
    Gillett DG; Ford GT
    Monogr Pathol; 1978; 19():21-42. PubMed ID: 370560
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal and pulmonary alterations induced in rats by a single injection of monocrotaline.
    Hayashi Y; Lalich JJ
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):392-6. PubMed ID: 4225339
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertensive pulmonary vascular disease in rats after prolonged feeding with Crotalaria spectabilis seeds.
    Smith P; Kay JM; Heath D
    J Pathol; 1970 Oct; 102(2):97-106. PubMed ID: 4396343
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of fulvine on pulmonary arteries and veins of the rat.
    Wagenvoort CA; Wagenvoort N; Dijk HJ
    Thorax; 1974 Sep; 29(5):522-9. PubMed ID: 4372744
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides).
    Chesney CF; Allen JR
    Am J Vet Res; 1973 Dec; 34(12):1577-81. PubMed ID: 4271643
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and toxicity of anacrotine, a pyrrolizidine alkaloid, in rats.
    Mattocks AR; Driver HE
    Chem Biol Interact; 1987; 63(1):91-104. PubMed ID: 3652286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophy of pulmonary arteries and arterioles with cor pulmonale in rats induced by seneciphylline, a pyrrolizidine alkaloid.
    Ohtsubo K; Ito Y; Saito M; Furuya T; Hikichi M
    Experientia; 1977 Apr; 33(4):498-9. PubMed ID: 862745
    [No Abstract]   [Full Text] [Related]  

  • 18. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
    Kido M
    Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.